Yeah this is a fair point. I think they have the cash to get through ok without raisingor sales but I suppose that relies on no further cost blow outs or things going wrong. The way I see it is that an announcement firming up their financial position will cause a sharp rise in the shsre price while presumed bad news is already factoresd in to some extent. Always nice to wait for certainty but the returns are lower of course.
- Forums
- ASX - By Stock
- TAP
- sale of zola/bianchi prospects.
sale of zola/bianchi prospects., page-192
Featured News
Add TAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online